World J Gastroenterol. 2010 August 14; 16(30): 3811-3815.
Published online 2010 August 14. doi: 10.3748/wjg.v16.i30.3811.
Minimally invasive esophagectomy
Fernando A Herbella and Marco G Patti.
Fernando A Herbella, Marco G Patti, Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, United States
Author contributions: Herbella FA wrote the manuscript; Patti MG revised the manuscript.
Correspondence to: Marco G Patti, MD, Professor, Director, Department of Surgery, University of Chicago Pritzker School of Medicine, 5841 S. Maryland Ave, MC 5095, Room G-201, Chicago, IL 60637, United States. mpatti@surgery.bsd.uchicago.edu
Telephone: +1-773-7024763 Fax: +1-773-7026120
Received April 24, 2010; Revised June 7, 2010; Accepted June 14, 2010;
Abstract
Esophageal resection is associated with a high morbidity and mortality rate. Minimally invasive esophagectomy (MIE) might theoretically decrease this rate. We reviewed the current literature on MIE, with a focus on the available techniques, outcomes and comparison with open surgery. This review shows that the available literature on MIE is still crowded with heterogeneous studies with different techniques. There are no controlled and randomized trials, and the few retrospective comparative cohort studies are limited by small numbers of patients and biased by historical controls of open surgery. Based on the available literature, there is no evidence that MIE brings clear benefits compared to conventional esophagectomy. Increasing experience and the report of larger series might change this scenario.
Keywords: Esophageal resection, Transhiatal esophagectomy, Transthoracic esophagectomy, Esophageal cancer, Minimally invasive esophagectomy, Laparoscopy, Thoracoscopy
INTRODUCTION
Esophageal cancer is a devastating disease. It was estimated in 2002 that 462 117 individuals developed the disease and 385 892 died worldwide[1], which corresponds to a mortality rate of 83.5%. Surgery has been considered an essential part of the treatment of patients with esophageal adenocarcinoma. However, surgery has been traditionally associated with a high morbidity and mortality rate. A lot of progress has been made since Earlam and Cunha-Melo in 1980 reviewed the literature and reported 29% mortality for esophagectomy[2]. Recent series have shown much improved rates, but they are still far from ideal. For these reasons, minimally invasive esophagectomy (MIE) brought high hopes to this field.
This final paper from a seminar on heartburn and adenocarcinoma focuses on the minimally invasive approach to esophagectomy; a treatment that is suitable for Barrett’s esophagus and high-grade dysplasia and for esophageal adenocarcinoma.
TECHNIQUE
The techniques for esophagectomy can be simplistically described as those that include thoracotomy (transthoracic) and those without thoracotomy (transhiatal). The same classification can be used for MIE. According to the preferred approach, thoracotomy can be replaced by thoracoscopy and/or laparotomy can be replaced by laparoscopy. Thus, the following different combinations can be found in the literature: (1) transhiatal esophagectomy - laparoscopy and cervicotomy[3,4]; (2) transthoracic esophagectomy (three-field) - laparoscopy, thoracoscopy and cervicotomy[5,6]; (3) transthoracic esophagectomy (three-field) - laparotomy, thoracoscopy and cervicotomy[6]; (4) transthoracic esophagectomy (three-field) - laparoscopy, thoracotomy and cervicotomy[7]; (5) transthoracic esophagectomy (Ivor Lewis) - laparoscopy and thoracoscopy[5]; (6) transthoracic esophagectomy (Ivor Lewis) - laparotomy and thoracoscopy[8]; and (7) transthoracic esophagectomy (Ivor Lewis) - laparoscopy and thoracotomy[9].
Laparoscopy
The laparoscopic approach to esophagectomy has the purpose of: (1) dissection of the abdominal esophagus and esophageal hiatus; (2) abdominal lymphadenectomy; (3) preparation of the stomach to replace the esophagus; (4) pyloroplasty or pyloromyotomy; and (5) placement of a feeding jejunostomy.
Dissection of the abdominal esophagus and esophageal hiatus follows the same principles of laparoscopic antireflux surgery. In summary, five abdominal ports are usually used. The abdominal esophagus and esophageal hiatus are dissected. The gastro-hepatic ligament is open, which preserves the right gastric artery. The greater curvature of the stomach is mobilized, which preserves the right gastroepiploic artery. The left gastric artery and coronary vein are isolated and divided with an endo-GIA stapler. A gastric conduit is constructed by dividing the stomach, starting on the lesser curvature and finishing at the angle of His. Pyloroplasty or pyloromyotomy is usually performed. The tip of the gastric conduit is sutured to the esophageal specimen that is retrieved through the neck or through the thorax if the anastomosis is performed in the chest[5,9,10]. Alternatively, the gastric conduit might be created through a mini-laparotomy[11]. The colon is rarely used for esophageal replacement during MIE.
Extended abdominal lymphadenectomy might be added to the procedure based on the philosophy adopted for the treatment of esophageal cancer by the surgeon. It is safe and feasible with a laparoscopic approach, after the lessons learned with laparoscopic treatment of gastric cancer[12].
Thoracoscopy
The thoracoscopic approach to esophagectomy has the purpose of: (1) dissection of the thoracic esophagus; (2) thoracic lymphadenectomy; and (3) esophageal anastomosis.
Dissection of the esophagus is performed using four ports in the right chest. Carbon dioxide insufflation is not considered necessary by most surgeons. The deflated lung is retracted anteriorly and the mediastinal pleura overlying the esophagus is divided. The azygos vein is then divided using an endo-GIA stapler with a vascular cartridge. A Penrose drain is placed around the esophagus to facilitate retraction. The esophagus is circumferentially mobilized from the esophageal hiatus up to the thoracic inlet. An esophageal anastomosis might be performed above the level of the azygos vein with the aid of a linear stapler. Otherwise, once the thoracoscopic dissection is completed, the operation can continue with cervicotomy, and the continuity of the digestive tract is restored with transposition of the stomach to the neck[5,9,10].
Similarly to the laparoscopic approach, extended mediastinal lymphadenectomy might be performed.
TECHNICAL VARIATIONS
Hand-assisted esophagectomy
Some surgeons perform transhiatal MIE using a laparoscopic approach to the abdomen but include a subxiphoid midline incision for manual mobilization of the mediastinal esophagus through a hand-port[5].
Prone position
Some surgeons have proposed a prone position for thoracoscopy instead of a left lateral decubitus approach[13,14]. This approach is used in order to improve ergonomics, operative time and pulmonary complications. The patient is placed in the prone position and the esophagus is approached through the right chest. The right lung is kept ventilated but it is collapsed due to the action of gravity and an 8-mmHg CO2 pneumothorax[13,14].
Palanivelu et al[13] have reported an incidence of 2% for pleural and pulmonary complications in 130 patients. Fabian et al[15] have shown no differences in blood loss, number of lymph nodes dissected, and complications in two small cohorts of patients operated in left lateral decubitus vs prone position. However, operation time was significant shorter. Although good results have been reported, this technique is not widely accepted.
Robotic surgery
Robotic surgery claims to have the advantages of: (1) eliminating the counter-intuitive motion of standard laparoscopy; (2) aligning the eyes and hands over the area of interest with improved ergonomics; (3) increasing freedom of instrument movement by allowing wrist and finger movements that standard laparoscopic instruments do not have; (4) minimizing instrument tremor; and (5) 3D stereoscopic vision with dual camera technology[16]. Different types of esophageal operations have been performed with the aid of a robotic platform. Cases of robotic esophagectomy have been shown to be safe and feasible, either through thoracoscopy[17] or laparoscopy[4].
Early results have shown a conversion rate ranging from 0% to 15%[4,18]. Operating time is still high for transthoracic robotic esophagectomy, at an average of 7.5 h, which leads to a high incidence of pulmonary complications that decreases with experience[18]. Long-term outcomes are still elusive.
Vagal-sparing esophagectomy
Vagal-sparing esophagectomy is an attractive alternative to conventional procedures to avoid postoperative complications associated with vagotomy. Vagal-sparing MIE has been described and popularized by the Portland Group[19]. The technique follows the same principles as open surgery: the vagal nerves are mobilized off the distal esophagus and stomach to the level of the pylorus; two nasogastric tubes are passed distally through the cervical esophagus and into the gastric remnant; the gastric remnant is divided and the nasogastric tubes are incorporated into the staple line; and finally, the esophagus is inverted, stripped out and removed through the cervicotomy[19].
OUTCOMES
Intraoperative complications are still frequent and they are the main cause for conversion to open surgery. During laparoscopy, bleeding is the main complication, either at the splenic hilum or parenchyma (often requiring splenectomy) or during division of gastric vessels at the time of the preparation of the gastric conduit[5]. Liver injury has also been reported[6,20]. During thoracoscopy, bleeding is reported as well[6]; however, the presence of pleural adhesions is the main cause for conversion[5,6]. Overall, the conversion rate ranges from 3% to 18%[5,6] with an average of 5%-7% depending on the technique[21,22].
Postoperative complications average 40%-50%, but can reach 80%[6,21,22]. Pleural and pulmonary complications still account for a significant proportion of morbidity; an average of 22%[22]. Nguyen et al[5] have reported, in a large series of 104 patients, that postoperative major morbidity occurred in 12.5%, especially anastomotic complications, staple line leaks and pulmonary complications. Minor complications occurred in an additional 15% of cases[5].
Review papers show a median length of intensive care unit stay of 2-5 d, and a median length of hospital stay of 9-18 d after MIE[21,22]. Mortality rate ranges between 0% and 4%[5,6,20-22].
COMPARISON WITH OPEN SURGERY
As far as we are aware, no randomized controlled trials have compared MIE and open esophagectomy to date. Available data suggests that MIE is similar but not superior to conventional esophagectomy.
Morbidity and mortality
MIE was expected to reduce the morbidity and mortality rate of esophageal resection when compared to conventional surgery. However, a recent meta-analysis[23] has shown similar results for major morbidity, pulmonary complications and mortality when MIE and open surgery are compared either to transhiatal or transthoracic esophagectomy. Nguyen et al[5] also have shown similar pulmonary complications when MIE and open cohorts were compared. Perry et al[24] have compared the outcomes of open and laparoscopic transhiatal esophagectomy in two sets of patients from different periods of time. They have found that lower intraoperative blood loss and overall length of hospital stay favor MIE. Complication rates were no different.
Cost
As far as we are aware, no studies have compared cost for MIE and open surgery. It is intuitive, however, that direct operative costs are higher for MIE, especially with the use of endoscopic staplers. Moreover, the clinical benefits of MIE are not yet proven to be greatly superior to open surgery in order to decrease indirect costs.
Oncological radicality
Advantages of minimally invasive techniques include a magnified view of the operative field. This advantage theoretically enhances the ability to perform more radical lymphadenectomy. In contrast, surgeons might be less confident to work close to important vascular structures without a tactile feeling and the possibility to use their hands to control bleeding. Reported experiences with different types of cancer, such as colon[25] and stomach[26], have shown a comparable number of lymph nodes retrieved when open or minimally invasive surgery are compared. MIE shows similar results. Decker et al[22] have shown a mean 10-27 lymph nodes were dissected in MIE, depending on the technique adopted, and these numbers are comparable to open surgery and considered adequate[27].
Survival is expectedly similar to open surgery with an average of 40% at 5 years[22].
Learning curve
It has been shown that esophagectomy outcomes are highly linked to the experience and volume of the centers performing the operation[28]. The same seems to be true for MIE[22]. To the best of our knowledge, no studies have defined the number of procedures necessary for these techniques to become safe and effective. Advanced laparoscopic skills and experience with major foregut surgery (open and laparoscopic) are clearly necessary.
CONCLUSION
Minimally invasive surgery has the advantages of better cosmetic results, reduced operative stress, postoperative immobility, and pain. These advantages are obtained by minimizing the incisions to obtain access to natural cavities, i.e. decreasing the external surgical stress. Minimally invasive surgery does not change, however, the internal part of the operation and the surgical stress determined by it. The minimally invasive approach has gained rapid acceptance and has become the gold-standard operation where external stress is higher than internal stress, such as for cholecystectomy and hiatal hernia repair[29,30]. In operations in which internal surgical stress is intensive, such as a Whipple procedure, the minimally invasive approach is questionable[31]. This is also true for MIE. This review shows that, even with a minimally invasive approach, patients are not discharged earlier and the clinical consequences of intense internal aggression, such as systemic inflammatory response syndrome[32], are still noticed after MIE. For these reasons and for the technical skills necessary to perform a MIE, it is not a disseminated and widely used approach for esophageal resection. Boone et al[33] have surveyed 269 surgeons, members of the International Society for Diseases of the Esophagus, the European Society of Esophagology Group, and the World Organization for Specialized Studies on Diseases of the Esophagus. They have found that MIE was the operation of choice for only 14% of the responders, while 60% of them never used the MIE approach. Similar results have been presented by Enestvedt et al[34]. Not surprisingly, they also have shown that MIE is performed more frequently by high-volume surgeons compared to those from low-volume centers.
The available literature on MIE is still crowded with heterogeneous studies with different techniques. As far as we are aware, there have been no controlled comparative trials, and the few retrospective comparative cohort studies have been limited by small numbers of patients and biased by historical controls of open surgery[22]. Moreover, few studies have included > 100 patients. Based on the available literature, there is no current evidence that MIE brings clear benefits compared to conventional esophagectomy. Growing experience and studies with larger numbers of patients could change this situation.
Footnotes
Peer reviewer: Piero Marco Fisichella, MD, Assistant Professor of Surgery, Medical Director, Swallowing Center, Loyola University Medical Center, Department of Surgery, Stritch School of Medicine, 2160 South First Avenue, Room 3226, Maywood, IL 60153, United States
S- Editor Wang YR L- Editor Kerr C E- Editor Lin YP
References
1.
International Agency for Research on Cancer. Available from: http://www-dep.iarc.fr/.
2.
Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381-390.[PubMed] [DOI]
3.
DePaula AL, Hashiba K, Ferreira EA, de Paula RA, Grecco E. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc. 1995;5:1-5.[PubMed]
4.
Galvani CA, Gorodner MV, Moser F, Jacobsen G, Chretien C, Espat NJ, Donahue P, Horgan S. Robotically assisted laparoscopic transhiatal esophagectomy. Surg Endosc. 2008;22:188-195.[PubMed] [DOI]
5.
Nguyen NT, Hinojosa MW, Smith BR, Chang KJ, Gray J, Hoyt D. Minimally invasive esophagectomy: lessons learned from 104 operations. Ann Surg. 2008;248:1081-1091.[PubMed] [DOI]
6.
Song SY, Na KJ, Oh SG, Ahn BH. Learning curves of minimally invasive esophageal cancer surgery. Eur J Cardiothorac Surg. 2009;35:689-693.[PubMed] [DOI]
7.
Benzoni E, Terrosu G, Bresadola V, Uzzau A, Intini S, Noce L, Cedolini C, Bresadola F, De Anna D. A comparative study of the transhiatal laparoscopic approach versus laparoscopic gastric mobilisation and right open transthoracic esophagectomy for esophageal cancer management. J Gastrointestin Liver Dis. 2007;16:395-401.[PubMed]
8.
Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007;245:232-240.[PubMed] [DOI]
9.
Kent MS, Schuchert M, Fernando H, Luketich JD. Minimally invasive esophagectomy: state of the art. Dis Esophagus. 2006;19:137-145.[PubMed] [DOI]
10.
Maloney JD, Weigel TL. Minimally invasive esophagectomy for malignant and premalignant diseases of the esophagus. Surg Clin North Am. 2008;88:979-990, vi.[PubMed] [DOI]
11.
Braghetto I, Csendes A, Cardemil G, Burdiles P, Korn O, Valladares H. Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc. 2006;20:1681-1686.[PubMed] [DOI]
12.
Shinohara T, Kanaya S, Taniguchi K, Fujita T, Yanaga K, Uyama I. Laparoscopic total gastrectomy with D2 lymph node dissection for gastric cancer. Arch Surg. 2009;144:1138-1142.[PubMed] [DOI]
13.
Palanivelu C, Prakash A, Senthilkumar R, Senthilnathan P, Parthasarathi R, Rajan PS, Venkatachlam S. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position--experience of 130 patients. J Am Coll Surg. 2006;203:7-16.[PubMed] [DOI]
14.
Fabian T, McKelvey AA, Kent MS, Federico JA. Prone thoracoscopic esophageal mobilization for minimally invasive esophagectomy. Surg Endosc. 2007;21:1667-1670.[PubMed] [DOI]
15.
Fabian T, Martin J, Katigbak M, McKelvey AA, Federico JA. Thoracoscopic esophageal mobilization during minimally invasive esophagectomy: a head-to-head comparison of prone versus decubitus positions. Surg Endosc. 2008;22:2485-2491.[PubMed] [DOI]
16.
Wilson EB. The evolution of robotic general surgery. Scand J Surg. 2009;98:125-129.[PubMed]
17.
van Hillegersberg R, Boone J, Draaisma WA, Broeders IA, Giezeman MJ, Borel Rinkes IH. First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc. 2006;20:1435-1439.[PubMed] [DOI]
18.
Boone J, Schipper ME, Moojen WA, Borel Rinkes IH, Cromheecke GJ, van Hillegersberg R. Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg. 2009;96:878-886.[PubMed] [DOI]
19.
Jobe BA, Reavis KM, Davis JJ, Hunter JG. Laparoscopic inversion esophagectomy: simplifying a daunting operation. Dis Esophagus. 2004;17:95-97.[PubMed] [DOI]
20.
Dapri G, Himpens J, Cadière GB. Minimally invasive esophagectomy for cancer: laparoscopic transhiatal procedure or thoracoscopy in prone position followed by laparoscopy?. Surg Endosc. 2008;22:1060-1069.[PubMed] [DOI]
21.
Gemmill EH, McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg. 2007;94:1461-1467.[PubMed] [DOI]
22.
Decker G, Coosemans W, De Leyn P, Decaluwé H, Nafteux P, Van Raemdonck D, Lerut T. Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg. 2009;35:13-20; discussion 20-21.[PubMed] [DOI]
23.
Biere SS, Cuesta MA, van der Peet DL. Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis. Minerva Chir. 2009;64:121-133.[PubMed]
24.
Perry KA, Enestvedt CK, Pham T, Welker M, Jobe BA, Hunter JG, Sheppard BC. Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage I esophageal adenocarcinoma. Arch Surg. 2009;144:679-684.[PubMed] [DOI]
25.
Paraskeva PA, Aziz O, Darzi A. Laparoscopic surgery for colon cancer. Surg Clin North Am. 2005;85:49-60, viii.[PubMed] [DOI]
26.
Strong VE, Devaud N, Karpeh M. The role of laparoscopy for gastric surgery in the West. Gastric Cancer. 2009;12:127-131.[PubMed] [DOI]
27.
Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46-50.[PubMed] [DOI]
28.
Gasper WJ, Glidden DV, Jin C, Way LW, Patti MG. Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: A follow-up analysis of another decade. Ann Surg. 2009;250:472-483.[PubMed]
29.
Finlayson SR, Laycock WS, Birkmeyer JD. National trends in utilization and outcomes of antireflux surgery. Surg Endosc. 2003;17:864-867.[PubMed] [DOI]
30.
Keus F, de Jong JA, Gooszen HG, van Laarhoven CJ. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev. 2006;CD006231.[PubMed]
31.
Mori T, Abe N, Sugiyama M, Atomi Y. Laparoscopic hepatobiliary and pancreatic surgery: an overview. J Hepatobiliary Pancreat Surg. 2002;9:710-722.[PubMed] [DOI]
32.
Kawahara Y, Ninomiya I, Fujimura T, Funaki H, Nakagawara H, Takamura H, Oyama K, Tajima H, Fushida S, Inaba H. Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus. 2010;23:329-339.[PubMed]
33.
Boone J, Livestro DP, Elias SG, Borel Rinkes IH, van Hillegersberg R. International survey on esophageal cancer: part I surgical techniques. Dis Esophagus. 2009;22:195-202.[PubMed] [DOI]
34.
Enestvedt CK, Perry KA, Kim C, McConnell PW, Diggs BS, Vernon A, O'Rourke RW, Luketich JD, Hunter JG, Jobe BA. Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons. Dis Esophagus. 2010;23:136-144.[PubMed]